| Janeen Chumley, | |
|
2011 Little Orchard St, Apt/suite, San Jose, CA 95125-1031 | |
| (559) 779-8907 | |
| Not Available |
| Full Name | Janeen Chumley |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2011 Little Orchard St, San Jose, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053759449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 10181 (California) | Primary |
| Provider Name | Orthopaedic And Neurological Rehab Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1225496540 PECOS PAC ID: 6507159126 Enrollment ID: O20160720000431 |
News Archive
Elsevier and the Royal Tropical Institute (KIT) in Amsterdam announced on 26th of August the signing of a Memorandum of Understanding (MoU) providing 150 researchers working in least-developed and low-income countries (for example Benin, Mozambique, Ethiopia, Togo etc.) with access to ScienceDirect and Scopus, Elsevier's online scientific research platform and flagship abstract and citation database.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic, inflammatory and neovascular diseases, today announced that data from preclinical studies of PRM-151 will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, being held May 1-5, 2011 in Ft. Lauderdale, FL.
Napoleone Ferrara, MD, distinguished professor of pathology and distinguished adjunct professor of ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the Ant-nio Champalimaud Vision Award in Lisbon, Portugal.
Women may perceive men with wider faces as more dominant and more attractive for short-term relationships, according to a new study in Psychological Science, a journal of the Association for Psychological Science.
Amgen (NASDAQ: AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janeen Chumley, 2011 Little Orchard St, Apt/suite, San Jose, CA 95125-1031 Ph: (559) 779-8907 | Janeen Chumley, 2011 Little Orchard St, Apt/suite, San Jose, CA 95125-1031 Ph: (559) 779-8907 |
News Archive
Elsevier and the Royal Tropical Institute (KIT) in Amsterdam announced on 26th of August the signing of a Memorandum of Understanding (MoU) providing 150 researchers working in least-developed and low-income countries (for example Benin, Mozambique, Ethiopia, Togo etc.) with access to ScienceDirect and Scopus, Elsevier's online scientific research platform and flagship abstract and citation database.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic, inflammatory and neovascular diseases, today announced that data from preclinical studies of PRM-151 will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, being held May 1-5, 2011 in Ft. Lauderdale, FL.
Napoleone Ferrara, MD, distinguished professor of pathology and distinguished adjunct professor of ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the Ant-nio Champalimaud Vision Award in Lisbon, Portugal.
Women may perceive men with wider faces as more dominant and more attractive for short-term relationships, according to a new study in Psychological Science, a journal of the Association for Psychological Science.
Amgen (NASDAQ: AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C).
› Verified 8 days ago
Marjereen Mirabueno, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 459 Mignot Ln, San Jose, CA 95111 Phone: 650-814-0720 | |
Mrs. Judith Wolf Ivan, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5998 Pilgrim Ave, San Jose, CA 95129 Phone: 408-252-9086 | |
Liza Bacal, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 75 N 13th St, San Jose, CA 95112 Phone: 408-295-2665 | |
Alyshia Ayn Abraham, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1327 Hillcrest Dr, San Jose, CA 95120 Phone: 408-649-5745 | |
Jerilyn Smith, OTR SWC Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Las Colinas Ln, San Jose, CA 95119 Phone: 408-284-2812 Fax: 408-284-2875 | |
Miss Mary-lynn Zweers, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2001 The Alameda, San Jose, CA 95126 Phone: 408-261-7777 Fax: 408-259-2273 | |
Patricia Pham Tran, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 556 N 1st St Ste 201, San Jose, CA 95112 Phone: 408-384-4993 Fax: 408-856-1246 |